Creative Medical Technology Holdings Inc (CELZ)
5.21
+0.12
(+2.36%)
USD |
NASDAQ |
Mar 27, 16:00
5.21
0.00 (0.00%)
Pre-Market: 20:00
Creative Medical Technology Holdings Gross Profit Margin (Quarterly): 60.00% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 60.00% |
September 30, 2023 | 60.00% |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | 69.35% |
September 30, 2022 | 70.91% |
June 30, 2022 | |
March 31, 2022 | 54.73% |
December 31, 2021 | 41.78% |
September 30, 2021 | 60.00% |
June 30, 2021 | 55.00% |
March 31, 2021 | |
December 31, 2020 | 54.29% |
Date | Value |
---|---|
September 30, 2020 | 77.14% |
June 30, 2020 | 61.29% |
March 31, 2020 | 66.28% |
December 31, 2019 | |
September 30, 2019 | 86.09% |
June 30, 2019 | 68.83% |
March 31, 2019 | 71.97% |
December 31, 2018 | 49.56% |
September 30, 2018 | 30.54% |
June 30, 2018 | 47.33% |
March 31, 2018 | 75.00% |
December 31, 2017 | -66.67% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
41.78%
Minimum
Dec 2021
86.09%
Maximum
Sep 2019
63.84%
Average
61.29%
Median
Jun 2020
Gross Profit Margin (Quarterly) Benchmarks
Avid Bioservices Inc | -18.37% |
Viking Therapeutics Inc | -- |
Avinger Inc | 19.62% |
Aptevo Therapeutics Inc | -- |
Absci Corp | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -39.54% |
Return on Assets | -36.83% |
Return on Invested Capital | -39.54% |
Profit Margin (Quarterly) | -55.95K% |
Operating Margin (Quarterly) | -59.06K% |